GDH-PQQ glucose test strips produced false high glucose readings that resulted in inappropriate insulin delivery and hypoglycemia, coma and death for some people with diabetes. The FDA gathered fatality reports involving the use of GDH-PQQ glucose test strips to help identify the common risk associated with the test strips.
The risk is specific to people that receive certain therapeutic sugar containing products or non-glucose sugars such as maltose, galactose and xylose. Apparently, the combination of insulin and these products produces a false high reading on the test strip report that triggers diabetics to inject inappropriate levels of insulin. People who are likely to use products that produce the risky sugar combination may be on peritoneal dialysis or have had recent surgery. Though, other people outside of these tow categories may be at risk.
We encourage people to share this information with friends, particularly elders who are less likely to be informed about defective products such as this. Our goal is to broaden consumer awareness to limit personal injury for diabetics. If you or a loved one has been injured by the GDH-PQQ glucose test strips, we encourage you to contact an attorney to learn about your legal rights.
